New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

23Feb

Member Press Release - BIVDA Member Randox Processes 10 Millionth COVID-19 Test

23 Feb, 2021 | Return|

RANDOX PROCESSES ITS 10 MILLIONTH COVID-19 TEST AND DETAILS INVESTMENT IN TESTING CAPACITY

 

Randox Laboratories has confirmed that it has processed its 10 millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone.  This achievement is based upon a £85 million investment since March 2020 in facilities and equipment at Randox’s laboratories in Northern Ireland.

 

As a key partner laboratory from initiation of the UK’s National Testing Programme in March 2020, Randox quickly ramped up its testing capacity.  Randox’s response has involved recruitment of over 850 new staff , the building and equipping of over 80,000 sq ft of new molecular laboratory space and the development of new innovations in testing technology. These efforts have seen Randox’s COVID-19 testing capacity grow from 150 tests per day in March 2020 to over 120,000 samples per day today, making Randox the largest throughput laboratory in the UK and Ireland and amongst the biggest in Europe.

 

Randox Founder and Managing Director, Dr Peter FitzGerald, said: This milestone is an incredible achievement and testament to the dedication and hard work of our teams, who have pulled together at a time of national crisis and whose non-stop efforts are vital to enable the country to return to both social and economic normality.

 

“We will continue to build our capacity and develop new cutting-edge testing equipment to support the fight against COVID-19.   We’ve all learnt from this pandemic the importance of early and accurate testing and Randox is committed to investing in diagnostic technology to meet future health challenges.”

 

  • ENDS -

 

Notes to editors

Randox is an international medical diagnostics company based in Antrim, Northern Ireland. Since its establishment in 1982, Randox has become a prominent world-leader in medical diagnostics and associated research and development, transforming the way patients are diagnosed and treated in over 145 countries. Randox is a premium provider of comprehensive health check services designed to empower its customers to take control of their health.

 

 

 

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858